GemVax AS, a subsidiary of Pharmexa A/S, is developing GV-1001, an injectable formulation of a promiscuous MHC class II peptide derived from the telomerase... P Nava-Parada,LA Emens - 《Current Opinion in Molecular Therapeutics》 被引量: 54发表: 2007年 Kael-Gemvax Forging Ahead Despite Can...
Site-specific determination of TTR-related functional peptides by using scanning tunneling microscopy 为功能的肽的设计和优化, unravelling 单个积木的结构以及整体的性质是首要的.TTR1,源于人的 transthyretin,形成纤丝的肽在象家庭淀粉的 polyneuropathy 和老年的全身... L Yu,Y Zheng,J Xu,... - 《纳米研...